| Literature DB >> 29607950 |
Takeshi Saraya1, Hiroki Nunokawa1, Kosuke Ohkuma1, Takayasu Watanabe1, Mitsuru Sada1, Manami Inoue1, Kojiro Honda1, Miku Oda1, Yukari Ogawa1, Masaki Tamura1, Takuma Yokoyama1, Daisuke Kurai1, Hirokazu Kimura2, Haruyuki Ishii1, Hajime Goto3, Hajime Takizawa1.
Abstract
Objective We investigated a novel diagnostic scoring system to differentiate Legionella pneumophila pneumonia from Streptococcus pneumoniae pneumonia. Methods We retrospectively reviewed the clinical data of 62 patients with L. pneumophila pneumonia (L-group) and 70 patients with S. pneumoniae pneumonia (S-group). Results The serum sodium (Na) levels tended to be lower according to the severity [age, dehydration, respiratory failure, orientation disturbance, low blood pressure (A-DROP)] score in the L-group. On a multivariate analysis, we found that four factors were independent predictive markers for inclusion in the L-group: relative bradycardia [hazard ratio (HR) 5.177, 95% confidence interval (CI): 1.072-24.993, p=0.041], lactate dehydrogenase (LDH) levels ≥292 IU/L (HR 6.804, 95% CI: 1.629-28.416, p=0.009), C-reactive protein (CRP) levels ≥21 mg/dL (HR 28.073, 95% CI: 5.654-139.462, p<0.001), and Na levels ≤137 meq/L (HR 5.828, 95% CI: 1.411-24.065, p=0.015). Furthermore, a total score [ranging from 0 to 4, the sum of the points for each factor (0 or 1)] ≥3 points indicated a higher probability of inclusion in the L-group than in the S-group. The diagnostic accuracy of a total score of 3 had a sensitivity of 36.3%, specificity of 100%, and area under the curve of 0.682 (95% CI: 0.558-0.806, p=0.004), and that of a total score of 4 had a sensitivity 27.4%, specificity of 98.2%, and area under the curve (AUC) of 0.627 (95% CI: 0.501-0.754, p=0.045). The diagnostic accuracy had low sensitivity but high specificity. Conclusions We found four markers that might be useful for differentiating L-group from S-group and created a novel diagnostic scoring system.Entities:
Keywords: Legionella pneumophila pneumonia; diagnostic scoring system; hyponatremia
Mesh:
Substances:
Year: 2018 PMID: 29607950 PMCID: PMC6172550 DOI: 10.2169/internalmedicine.0491-17
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271
Demographical and Clinical Details of Patients with Legionella Pneumophila Pneumonia and Streptococcus Pneumoniae Pneumonia.
| p value | ||||||
|---|---|---|---|---|---|---|
| Age (years) | 68.5 (55-80.5) | 72.5 (43.8-83.0) | 0.473 | |||
| Sex (M/F) | 54/8 | 38/32 | <0.001 | |||
| Underlying respiratory diseases | 12/28 (42.9%) | 31/43 (72.1%) | 1.0 | |||
| Inpatients | 61 (98.4%) | 34 (48.6%) | <0.001 | |||
| Smoker | 24/28 (85.7%) | 31/45 (68.9%) | 0.162 | |||
| Initial onset to first visit to a local or our hospital (days) | 3.0 (1.0-5.0) | 3.5 (1.8-7.0) | 0.028 | |||
| Body temperature (°C) | 38.8 (37.2-39.3) | 38.0 (37.0-38.9) | <0.001 | |||
| Heart rate | 108 (94-120) | 100 (84-107) | <0.001 | |||
| Relative bradycardia | 24/54 (44.4%) | 10/64 (15.6%) | 0.001 | |||
| Respiratory failure# | 11/45 (24.45) | 22/54 (40.7%) | 0.133 | |||
| Diagnostic methods | ||||||
| Positive for urinary antigen test | 58/60 (96.7%) | 25/47 (53.2%) | <0.001 | |||
| Culture positive | 8/21 (38.1%) | 70 (100%) | <0.001 | |||
| PCR positive | 5/6 (83.3%) | NA | ||||
| A-DROP* | ||||||
| 0 | 11 (20%) | 20 (35.7%) | 0.09 | |||
| 1 | 18 (32.7%) | 14 (25%) | 0.407 | |||
| 2 | 13 (23.6%) | 6 (10.7%) | 0.082 | |||
| 3 | 9 (16.4%) | 12 (21.4%) | 0.629 | |||
| 4 | 3 (5.5%) | 3 (5.4%) | 1.0 | |||
| 5 | 1 (1.8%) | 1 (1.8%) | 1.0 |
All data are expressed as median (25th-75th percentile) or number (%).
*A-DROP score was available in only 55 patients with Legionella pneumophila pneumonia and 56 patients with S. pneumoniae pneumonia
#Definition of respiratory failure is SpO2 less than 90% or respiratory status required oxygen supply
PCR: polymerase chain reaction, A-DROP: age, dehydration, respiratory failure, orientation disturbance, low blood pressure, NA: not available
Comparison of the Serum Laboratory Results between the Patients with Legionella Pneumophila Pneumonia and S. Pneumoniae Pneumonia.
| p value | |||||
|---|---|---|---|---|---|
| WBC (×103/μL) | 10,600 (7,600-13,800) | 10,900 (8,350-14,525) | 0.662 | ||
| LDH (IU/L) | 378 (299-523) | 224 (197-283) | <0.001 | ||
| AST (IU/L) | 66.5 (36-132) | 23 (16-33.5) | <0.001 | ||
| ALT (IU/L) | 43.5 (23.5-75.3) | 15 (12-25) | <0.001 | ||
| Na (meq/L) | 135.5 (132-139) | 139 (137-141) | <0.001 | ||
| CRP (mg/dL) | 27.4 (22.1-38.2) | 7.8 (2.9-14.9) | <0.001 |
All data are expressed as median (25th-75th percentile).
WBC: white blood cell count, AST: aspartate aminotransferase, ALT: alanine aminotransferase, CRP: C-reactive protein, LDH: lactate dehydrogenase
Figure 1.The distribution of the serum sodium levels in Legionella pneumophila pneumonia categorized by the A-DROP score. All data are expressed as the median (25th-75th percentile). A-DROP: age, dehydration, respiratory failure, orientation disturbance, low blood pressure
Figure 2.A comparison of the serum sodium levels in groups categorized by the A-DROP score. A-DROP<1 means A-DROP 0. A-DROP<2 means A-DROP ≤0 plus A-DROP 1. A-DROP<3 means A-DROP ≤0 plus A-DROP 1 plus A-DROP 2. A-DROP<4 means A-DROP ≤0 plus A-DROP 1 plus A-DROP 2 plus A-DROP 3. All data are expressed as the median (25th-75th percentile). A-DROP: age, dehydration, respiratory failure, orientation disturbance, low blood pressure
Figure 3.Differentiating Legionella pneumophila pneumonia from Streptococcus pneumoniae pneumonia using the serum CRP, LDH, and sodium levels. AUC: area under the curve.
Univariate Analysis of Discrimination between Legionella Pneumophila Pneumonia and S. Pneumoniae Pneumonia.
| Hazard ratio | 95% CI | p value | ||||
|---|---|---|---|---|---|---|
| Age | 1.002 | 0.981-1.022 | 0.881 | |||
| Sex | 5.684 | 2.360-13.689 | <0.001 | |||
| Smoker | 2.71 | 0.790-9.292 | 0.113 | |||
| Underlying respiratory diseases | 0.944 | 0.390-2.285 | 0.898 | |||
| Initial onset to visit to a local or our hospital (days) | 1.163 | 1.007-1.344 | 0.04 | |||
| Respiratory failure* | 0.471 | 0.197-1.123 | 0.089 | |||
| WBC | 1 | 1.0-1.0 | 0.447 | |||
| LDH | 0.992 | 0.988-0.996 | <0.001 | |||
| LDH ≥292 IU/L | 11.667 | 4.475-30.417 | <0.001 | |||
| Na | 1.272 | 1.144-1.415 | <0.001 | |||
| Na ≤137 meq/L | 12.706 | 5.267-30.652 | <0.001 | |||
| CRP | 0.85 | 0.802-0.901 | <0.001 | |||
| CRP ≥21 mg/dL | 36.667 | 12.001-112.032 | <0.001 | |||
| Heart rate | 0.977 | 0.957-0.997 | 0.026 | |||
| Body temperature | 0.664 | 0.488-0.902 | 0.009 | |||
| Relative bradycardia | 4.320 | 1.824-10.231 | 0.001 |
#Definition of respiratory failure is SpO2 less than 90% or respiratory status required oxygen supply
WBC: white blood cell count, CRP: C-reactive protein, LDH: lactate dehydrogenase
Multivariate Analysis of Discrimination between Legionella Pneumophila Pneumonia and S. Pneumoniae Pneumonia.
| HR | 95% CI | p value | ||||
|---|---|---|---|---|---|---|
| Relative bradycardia | 5.177 | 1.072-24.993 | 0.041 | |||
| LDH ≥292 (IU/L) | 6.804 | 1.629-28.416 | 0.009 | |||
| CRP ≥21 (mg/dL) | 28.073 | 5.651-139.462 | <0.001 | |||
| Na ≤137 (meq/L) | 5.828 | 1.411-24.065 | 0.015 |
CRP: C-reactive protein, HR: hazard ratio, LDH: lactate dehydrogenase
Multivariate Analysis of Discrimination between Legionella Pneumophila Pneumonia and S. Pneumoniae Pneumonia, with Specific Reference to the Patients with A-DROP 0, 1, 2, and 3.
| HR | 95% CI | p value | ||||
|---|---|---|---|---|---|---|
| Relative bradycardia | 5.797 | 1.103-30.474 | 0.038 | |||
| LDH ≥292 (IU/L) | 6.462 | 1.445-28.902 | 0.015 | |||
| CRP ≥21 (mg/dL) | 22.243 | 4.132-119.742 | <0.001 | |||
| Na ≤137 (meq/L) | 4.812 | 1.059-21.868 | 0.042 |
CRP: C-reactive protein, HR: Hazard ratio, LDH: lactate dehydrogenase
Figure 4.Patients with Legionella pneumophila pneumonia and Streptococcus. pneumoniae pneumonia according to the diagnostic score. The numbers in the boxes represent the total numbers of patients.
Diagnostic Accuracy of the Total Score in Differentiating Legionella Pneumophila Pneumonia from S. Pneumoniae Pneumonia.
| Total score | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | AUC | 95% CI | p value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 57.1 | 0 | 49.2 | 0.286 | 0.182-0.389 | 0.001 | |||||||
| 1 | 6.1 | 61.1 | 8.7 | 51.6 | 0.336 | 0.223-0.449 | 0.011 | |||||||
| 2 | 30.3 | 81.5 | 50 | 65.7 | 0.559 | 0.432-0.686 | 0.301 | |||||||
| 3 | 36.3 | 100 | 100 | 72.7 | 0.682 | 0.558-0.806 | 0.004 | |||||||
| 4 | 27.3 | 98.2 | 90 | 69.6 | 0.627 | 0.501-0.754 | 0.045 |
AUC: area under the curve, PPV: positive predictive value, NPV: negative predictive value
Specifications of Different Clinical Models.
| Model | All cases* | Especially focused on the | ||||
|---|---|---|---|---|---|---|
| Independent variables | AUC (95% CI) | AUC (95% CI) | ||||
| Model 1 | Relative bradycardia | 0.653 (0.532-0.775, p=0.015) | 0.664 (0.535-0.794, p=0.017) | |||
| Model 2 | LDH ≥292 (IU/L) | 0.773 (0.669-0.878, p<0.001) | 0.786 (0.676-0.896, p<0.001) | |||
| Model 3 | CRP ≥21 (mg/dL) | 0.828 (0.731-0.925, p<0.001) | 0.827 (0.722-0.931, p<0.001) | |||
| Model 4 | Na ≤137 (meq/L) | 0.761 (0.656-0.865, p<0.001) | 0.752 (0.637-0.867, p<0.001) | |||
| Model 5 | LDH ≥292 (IU/L) and CRP ≥21 (mg/dL) | 0.795 (0.683-0.907, p<0.001) | 0.791 (0.673-0.908, p<0.001) | |||
| Model 6 | LDH ≥292 (IU/L) and Na ≤137 (meq/L) | 0.697 (0.570-0.825, p=0.003) | 0.708 (0.575-0.840, p=0.004) | |||
| Model 7 | LDH ≥292 (IU/L) and relative bradycardia | 0.797 (0.684-0.910, p<0.001) | 0.797 (0.679-0.915, p<0.001) | |||
| Model 8 | CRP ≥21 (mg/dL) and Na ≤137 (meq/L) | 0.664 (0.534-0.794, p=0.014) | 0.654 (0.516-0.792, p=0.031) | |||
| Model 9 | CRP ≥21 (mg/dL) and relative bradycardia | 0.714 (0.588-0.840, p=0.001) | 0.726 (0.595-0.856, p=0.002) | |||
| Model 10 | Na ≤137 (meq/L) and relative bradycardia | 0.790 ( 0.675-0.906, p<0.001) | 0.791 (0.671-0.912, p<0.001) | |||
| Model 11 | LDH ≥292 (IU/L) and CRP ≥21 (mg/dL) and Na ≤137 (meq/L) | 0.690 (0.562-0.819, p=0.004) | 0.684 (0.548-0.820, p=0.01) | |||
| Model 12 | LDH ≥292 (IU/L) and CRP ≥21 (mg/dL) and relative bradycardia | 0.674 (0.544-0.804, p=0.009) | 0.684 (0.548-0.820, p=0.01) | |||
| Model 13 | LDH ≥292 (IU/L) and Na ≤137 (meq/L) and bradycardia | 0.640 (0.508-0.772, p=0.035) | 0.649 (0.510-0.787, p=0.03) |
*All cases consist of Legionella pneumophila pneumonia (n=62) and S. pneumoniae pneumonia (n=70)
**A-DROP<4 group consist of Legionella pneumophila pneumonia (n=42) and S. pneumoniae pneumonia (n=40).
LDH: lactate dehydrogenase, CRP: C-reactive protein
Figure 5.Change in the serum sodium levels during the clinical course.
Comparison of the RICO’s Score and New Score.
| L-group | S-group | Sensitivity (%) | Specificity (%) | AUC (95%CI, p value) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| RICO’s score (≥4) | 16 | 3 | 47.1 | 95.6 | 0.713 (0.597-0.830, p<0.001) | |||||
| RICO’s score (≥5) | 6 | 2 | 17.6 | 97.1 | 0.574 (0.451-0.696, p=0.228) | |||||
| New score (≥3) | 21 | 1 | 63.6 | 98.2 | 0.809 (0.703-0.916, p<0.001) | |||||
| New score (≥4) | 9 | 1 | 27.3 | 98.2 | 0.627 (0.561-0.754, p=0.045) |
Total number of patients (L-group, S-group) whose data can be available for RICO’s score and/or New score were (n=34, n=68), (n=33, n=56), respectively.
AUC: area under the curve, L-group: Legionella pneumophila pneumonia group, S-group: St reptococcus pneumoniae pneumonia group, 95%CI: 95% confidence interval